Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting.
Oncotarget
; 8(40): 69025-69037, 2017 Sep 15.
Article
en En
| MEDLINE
| ID: mdl-28978178
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Oncotarget
Año:
2017
Tipo del documento:
Article